Insider · SEC Form 4 filer

Orbimed Advisors LLC

Companies

Where they file as an insider

Electra Therapeutics (ETRA) Director, 10% owner Latest filing Nov 10, 2026
Aspen Neuroscience (ASPE) Director, 10% owner Latest filing Nov 2, 2026
Scribe Therapeutics (SCTX) Director Latest filing Jul 27, 2026
Sionna Therapeutics (SION) Director Latest filing Jun 30, 2026
Enliven Therapeutics (ELVN) 10% owner Latest filing Jun 22, 2026
Adicet Bio (ACET) 10% owner Latest filing Oct 8, 2025
PMV Pharmaceuticals (PMVP) 10% owner Latest filing Sep 10, 2025
Turnstone Biologics (TSBX) Director Latest filing Aug 8, 2025

And 10 more companies with older filings.

Track record

Did their buys beat the typical stock?

Open-market buys22
Quarters checked 6 months later1
Beat the typical stock —
Quarters too new to check3

Too soon to tell. 1 quarter has finished so far. We show a record once 3 have.

Electra Therapeutics (ETRA) Bought Nov 3–10, 2026 · $4.35M · 564,687 shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
Aspen Neuroscience (ASPE) Bought Nov 2, 2026 · $15M · 1M shares Too new Too new. Its 6-month check uses prices as of Jun 30, 2027.
Scribe Therapeutics (SCTX) Bought Jul 27, 2026 · $15M · 1M shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Upstream Bio (UPB) Bought Oct 15, 2024 · $14M · 825,000 shares Behind typical Dec 31, 2024 $16.44 → Jun 30, 2025 $10.98 · −33.2% (typical stock −3.4%)
MBX Biosciences (MBX) Bought Sep 16, 2024 · $12M · 750,000 shares Not counted Not counted. We have no fund price for this stock on both Sep 30, 2024 and Mar 31, 2025.

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist